To explore targets in HCC in the context of the TGF-β pathway, we analyzed genetic alterations of PJA1 in a significant number of HCCs and determined an interaction between PJA1 and HMGA2. The gene discussed is HMGA2; the disease is hepatocellular carcinoma.